We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Coronavirus Disease 2019–Associated Mucormycosis: Risk Factors and Mechanisms of Disease.
- Authors
Narayanan, Shivakumar; Chua, Joel V; Baddley, John W
- Abstract
The severe surge of coronavirus disease 2019 (COVID-19) cases on the Indian subcontinent in early 2021 was marked by an unusually high number of COVID-19–associated mucormycosis (CAM) cases reported during this same period. This is significantly higher than predicted based on available data about prevalence and risk factors for this condition. This may be due to an unusual alignment of multiple risk factors for this condition. There is high background prevalence of mucormycosis in India likely from a high prevalence of risk factors, including undiagnosed or poorly controlled diabetes. COVID-19–induced immune dysregulation and immune suppression from steroid therapy increase the risk. The role of environmental exposure is unclear. System factors such as lack of access to healthcare during a pandemic may result in delayed diagnosis or suboptimal management with potentially poor outcomes. Here, we review currently identified risk factors and pathogenesis of CAM in a pandemic surge.
- Subjects
INDIA; DIABETES complications; COVID-19; HEALTH services accessibility; STEROIDS; ZYGOMYCOSIS; IMMUNE system; DISEASE risk factors
- Publication
Clinical Infectious Diseases, 2022, Vol 74, Issue 7, p1279
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciab726